In early HCC, DNA methylation inhibits the binding of p53 to the tumor suppressor Zinc‐finger protein 334 (ZNF334), thereby reducing p53 expression, further emphasizing the importance of DNA methylation in the pathogenesis of HCC [87]. Here, TP53 is linked to hepatocellular carcinoma.